Integrin Antagonists
Integrin Antagonist is a pharmacological agent that selectively inhibits integrin receptors, a class of cell adhesion molecules, by blocking their interaction with ligands to modulate inflammatory cell trafficking and activation in the context of inflammatory disease therapeutics.
807
Publications
60.1K
Citations
5K
Authors
1.1K
Institutions
Publications per year
2017–2026
131
Variants
Integrin Antagonist
807
Definition of Two Angiogenic Pathways by Distinct α <sub>v</sub> Integrins
Martin Friedlander, Peter C. Brooks, Robert W. Shaffer et al. · Science · 1995 · 1.3K citations
1–5 of 807
5K
23
h-index
Albany College of Pharmacy and Health Sciences, United States
27 publications · 1.5K citations
20
h-index
20
h-index
15
h-index
14
h-index
1–5 of 5K
1.1K
Merck KGaA, Darmstadt (Germany)
Darmstadt, Germany
27 h-index
96 publications
18.5K citations
Harvard University
Cambridge, United States
24 h-index
106 publications
10.8K citations
Scripps Research Institute
San Diego, United States
22 h-index
80 publications
37.7K citations
Technical University of Munich
Munich, Germany
22 h-index
135 publications
23.3K citations
University of California San Diego
San Diego, United States
21 h-index
71 publications
8.1K citations

University of Milan
Milan, Italy
17 h-index
103 publications
4.4K citations
Temple University
Philadelphia, United States
16 h-index
60 publications
3.6K citations

Biogen (United States)
Cambridge, United States
16 h-index
92 publications
8.3K citations
1–8 of 1.1K
42 publications · 3.6K citations
31
h-index
Repository · 40 publications · 4.2K citations
29
h-index
JBC · 29 publications · 2.8K citations
26
h-index
31 publications · 720 citations
17
h-index
JCI · 15 publications · 3.3K citations
14
h-index
1–5